Exhibit 99.1 Nevro Reports First-Quarter 2024 Financial Results Announces Additional Restructuring Steps to Advance Strategy and Accelerate Profitability Raises Adjusted EBITDA Guidance and Reaffirms Revenue Guidance for Full-Year 2024 Promotes Christofer Christoforou to Chief Operating Officer REDWOOD CITY, California – May 7, 2024 – Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today reported its first ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2023 or Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐ Ind ...

Nevro Corp. (NYSE:NVRO) Q4 2023 Results Conference Call February 21, 2024 5:00 PM ET Company Participants Angie McCabe - Vice President Investor Relations and Corporate Communication Kevin Thornal - President and Chief Executive Officer Rod MacLeod - Chief Financial Officer Conference Call Participants Kallum Titchmarsh - Morgan Stanley Nathan Treybeck - Wells Fargo Shagun Singh - RBC Capital Adam Maeder - Piper Sandler Joanne Wuensch - Citi Richard Newitter - Truist Brandon Vazquez - William Blair Bill Plo ...

Nevro Corp. (NYSE:NVRO) Q3 2023 Results Conference Call November 1, 2023 4:30 PM ET Company Participants Kevin Thornal - President and Chief Executive Officer Rod MacLeod - Senior Vice President and Chief Financial Officer Conference Call Participants Shagun Singh - RBC Capital Brad Bowers - Mizuho Securities Simran Kaur - Piper Sandler David Turkaly - JMP Securities Operator Hello. My name is Chris, and I will be your conference operator today. At this time, I would like to welcome everyone to Nevro Third ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-36715 Nevro Corp. (Exact name of registrant as specified in its charter) Delaware 56-2568057 (State or other jurisdiction of incorporation or organization) ( ...

Nevro Corp. (NYSE:NVRO) Q2 2023 Earnings Conference Call August 1, 2023 4:30 PM ET Company Participants Greg Chodaczek - Gilmartin Group LLC Kevin Thornal - President and CEO Rod MacLeod - Chief Financial Officer Conference Call Participants Anthony Petrone - Mizuho Group Simran Kaur - Piper Sandler Nathan Treybeck - Wells Fargo Allen Gong - JPMorgan Brandon Vazquez - William Blair Brad Bowers - Mizuho Securities David Turkaly - JMP Securities Operator Ladies and gentlemen, good afternoon. My name is Abby, ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-36715 Nevro Corp. (Exact name of registrant as specified in its charter) Delaware 56-2568057 (State or other jurisdiction of incorporation or organization) (I.R.S ...

1Q 2023 Earnings Call Presentation A P RI L 2 6 , 2 0 2 3 Forward-Looking Statements 2 Management uses certain non-GAAP financial measures, most specifically Adjusted EBITDA, as a supplement to GAAP financial measures to further evaluate the company's operating performance period over period, analyze the underlying business trends, assess performance relative to competitors and establish operational objectives. • Stock-based compensation expense – The company excludes non-cash costs related to the company's ...

Nevro Corp. (NYSE:NVRO) Q1 2023 Earnings Conference Call April 26, 2023 4:30 PM ET Company Participants Julie Dewey - Chief Corporate Communications and Investor Relations Officer Keith Grossman - Executive Chairman Kevin Thornal - President and CEO Rod MacLeod - Chief Financial Officer Conference Call Participants Larry Biegelsen - Wells Fargo Bill Plovanic - Canaccord Allen Gong - J.P. Morgan Adam Maeder - Piper Sandler Mike Sarcone - Jefferies Anthony Petrone - Mizuho Operator Good afternoon. My name is ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-36715 Nevro Corp. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 56-2568057 (I.R. ...